• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neutralizing Antibodies Induced by Gene-Based Hydrodynamic Injection Have a Therapeutic Effect in Lethal Influenza Infection

tetano

Editor, Senior Moderator
Front Immunol. 2018 Jan 24;9:47. doi: 10.3389/fimmu.2018.00047. eCollection 2018.
[h=1]Neutralizing Antibodies Induced by Gene-Based Hydrodynamic Injection Have a Therapeutic Effect in Lethal Influenza Infection.[/h] Yamazaki T[SUP]1,[/SUP][SUP]2[/SUP], Nagashima M[SUP]2[/SUP], Ninomiya D[SUP]2[/SUP], Ainai A[SUP]3[/SUP], Fujimoto A[SUP]2[/SUP], Ichimonji I[SUP]1[/SUP], Takagi H[SUP]1[/SUP], Morita N[SUP]1[/SUP], Murotani K[SUP]4[/SUP], Hasegawa H[SUP]3[/SUP], Chiba J[SUP]2[/SUP], Akashi-Takamura S[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The influenza virus causes annual epidemics and occasional pandemics and is thus a major public health problem. Development of vaccines and antiviral drugs is essential for controlling influenza virus infection. We previously demonstrated the use of vectored immune-prophylaxis against influenza virus infection. We generated a plasmid encoding neutralizing IgG monoclonal antibodies (mAbs) against A/PR/8/34 influenza virus (IAV) hemagglutinin (HA). We then performed electroporation of the plasmid encoding neutralizing mAbs (EP) in mice muscles and succeeded in inducing the expression of neutralizing antibodies in mouse serum. This therapy has a prophylactic effect against lethal IAV infection in mice. In this study, we established a new method of passive immunotherapy after IAV infection. We performed hydrodynamic injection of the plasmid encoding neutralizing mAbs (HD) involving rapid injection of a large volume of plasmid-DNA solution into mice via the tail vein. HD could induce neutralizing antibodies in the serum and in several mucosal tissues more rapidly than in EP. We also showed that a single HD completely protected the mice even after infection with a lethal dose of IAV. We also established other isotypes of anti-HA antibody (IgA, IgM, IgD, and IgE) and showed that like anti-HA IgG, anti-HA IgA was also effective at combating upper respiratory tract IAV infection. Passive immunotherapy with HD could thus provide a new therapeutic strategy targeting influenza virus infection.


[h=4]KEYWORDS:[/h] gene therapy; hemagglutinin; hydrodynamics procedure; influenza; neutralizing antibody; passive immunotherapy

PMID: 29416543 PMCID: PMC5787536 DOI: 10.3389/fimmu.2018.00047
Free full text
 
Back
Top Bottom